FMR CORP 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Applied Therapeutics, Inc. APLT |
FMR CORP | 2,427,436 3.143% |
-544,935 (-18.33%) |
Filing |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | Applied Therapeutics, Inc. APLT |
FMR CORP | 2,972,371 6.184% |
2,069,896 (+229.36%) |
Filing |
| 2022-03-10 09:48 am Sale |
2022-03-09 | 13G | Applied Therapeutics, Inc. APLT |
FMR CORP | 902,475 3.442% |
-1,341,001 (-59.77%) |
Filing |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | Applied Therapeutics, Inc. APLT |
FMR CORP | 2,243,476 8.557% |
19,511 (+0.88%) |
Filing |
| 2021-02-08 10:15 am Sale |
2021-02-05 | 13G | Applied Therapeutics, Inc. APLT |
FMR CORP | 2,223,965 9.889% |
-3,992 (-0.18%) |
Filing |
| 2020-08-10 09:25 am Purchase |
2020-08-07 | 13G | Applied Therapeutics, Inc. APLT |
FMR CORP | 2,227,957 10.069% |
2,227,957 (New Position) |
Filing |